UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000036621
Receipt No. R000041721
Scientific Title Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Date of disclosure of the study information 2019/10/01
Last modified on 2019/04/28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Acronym Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Scientific Title Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Scientific Title:Acronym Single-arm feasibility study of laparoscopic gastrectomy for upper-third gastric cancer and esophago-gastric junction cancer
Region
Japan

Condition
Condition Upper-third gastric cancer and esophago-gastric junction cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to validate non-inferiority in safety of laparoscopic gastrectomy compared to open gastrectomy for cT1N2-3, cT2N0-3, cT3N0 and cT4aN0 upper-third gastric cancer or esophago-gastric junction cancer.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Incidence of anastomotic leakage
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Laparoscopic proximal gastrectomy or laparoscopic total gastrectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Pathologically diagnosed as gastric or esophago-gastric adenocarcinoma.
2) Curatively resectable cT1N2-3M0, cT2N0-3M0, cT3N0M0 and cT4N0M0 (excluding bulky N2) cancer by proximal or total gastrectomy without splenectomy.
3) Older than 20 y.o.
4) PS 0~2
5) No previous treatment for gastric cancer.
6) BMI<35
7) Consented to be enrolled to the trial from participant him/herself.
Key exclusion criteria 1) Double cancer
2) cT4b
3) P1, Cy1 or cM1
4) Cases of received neoadjuvant treatment.
5) Pregnant or breast feeding.
6) Mental disorder
7) Continuous systemic administration of steroid.
8) Infectious disease with systemic treatment.
9) Uncontrollable diabetes mellitus.
10) Unstable coronary angina or history of MI within 6 months.
11) Respiratory disease with continuous administration of oxygen.
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Soya
Middle name
Last name Nunobe
Organization Cancer Institute Hospital of JFCR
Division name Gastroenterology Center
Zip code 1358550
Address 3-8-31, Ariake, Koto-ku, Tokyo, Japan
TEL +81-3-3520-0111
Email souya.nunobe@jfcr.or.jp

Public contact
Name of contact person
1st name En
Middle name
Last name Amada
Organization Cancer Institute Hospital of JFCR
Division name Gastroenterology Center
Zip code 1358550
Address 3-8-31, Ariake, Koto-ku, Tokyo, Japan
TEL +81-3-3520-0111
Homepage URL
Email en.amada@jfcr.or.jp

Sponsor
Institute JFCR
Institute
Department

Funding Source
Organization JFCR
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Cancer Institute Hospital of JFCR
Address 3-8-31, Ariake, Koto-ku, Tokyo, Japan
Tel +81-3-3520-0111
Email en.amada@jfcr.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 10 Month 01 Day
Date of IRB
Anticipated trial start date
2019 Year 10 Month 01 Day
Last follow-up date
2032 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 04 Month 28 Day
Last modified on
2019 Year 04 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041721

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.